ArticlePolymers2026
A Composite Based on
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Laser Surface Treatment of Polymethacrylate Materials for Biocompatibility Improvement.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The development of biodegradable, biocompatible materials with inherent antibacterial properties, suitable for 3D printing, is a key challenge in modern materials science. Composites based on PLA and copper nanoparticles (NPs) are promising candidates for such a material. A protocol of the low-temperature incorporation of 0.1% Cu NPs or 0.1% CuO NPs into a PLA was developed. The dependence of the materials' physicochemical properties on nanoparticle composition was evaluated. Cu and CuO NPs were synthesized via liquid-phase laser ablation and had sizes of 25 and 80 nm, with modal zeta potential values of +31 and +42 mV, respectively. The incorporation of Cu NPs enhances the tensile strength and Young's modulus of PLA, and improves antibacterial properties. The PLA + 0.1% CuO or PLA + 0.1% Cu nanoparticles inhibited the growth of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.